Modified Checklist With Follow-Up Valid for Autism in Toddlers

Share this content:
Modified Checklist With Follow-Up Valid for Autism in Toddlers
Modified Checklist With Follow-Up Valid for Autism in Toddlers

MONDAY, Aug. 22, 2016 (HealthDay News) -- The Modified Checklist for Autism in Toddlers (M-CHAT) with Follow-up Interview (M-CHAT/F), which can be administered by minimally trained primary care physicians (PCPs) is valid and reliable, according to a study published online Aug. 19 in Pediatrics.

Raymond Sturner, M.D., from the Johns Hopkins University School of Medicine in Baltimore, and colleagues examined the feasibility, validity, and reliability of the M-CHAT/F by PCPs with online prompts at the time of a positive M-CHAT screen. A total of 197 M-CHAT/Fs triggered by positive M-CHAT screens were completed by 47 PCPs from 22 clinics via the same secure web-based platform that parents used to complete M-CHATs before an 18- or 24-month well-child visit. A second M-CHAT/F was administered by trained research assistants (RA). As criterion measures, the Autism Diagnostic Observation Schedule, Second Edition, and the Mullen Scales of Early Learning were administered; measures of agreement were compared between PCPs and RAs.

The researchers observed 86.6 percent agreement between PCPs and RAs (Cohen's κ, 0.72). Significant equivalence was seen for all measures in comparison of sensitivity, specificity, positive predictive value (PPV), and overall accuracy for M-CHAT/F between PCPs and RAs. There was significant improvement in PPV for use of the MCAT/F by PCPs versus M-CHAT alone.

"Minimally trained PCPs can administer the M-CHAT/F reliably and efficiently during regular well-child visits, increasing PPV without compromising detection," the authors write.

Several authors disclosed financial ties to Total Child Health.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

ASH: Synthetic Blood Cell Passes Proof-of-Concept Testing

ASH: Synthetic Blood Cell Passes Proof-of-Concept Testing

Synthetic product made from purified human hemoglobin proteins coated with a synthetic polymer

Fewer School Shootings in States With Tighter Gun Laws

Fewer School Shootings in States With Tighter Gun ...

Study also found that states that spent more money on mental health care, education saw less violence

SABCS: No Survival Benefit Seen for Letrozole Beyond Five Years

SABCS: No Survival Benefit Seen for Letrozole Beyond ...

Study found women who continued with letrozole did experience other benefits, however

is free, fast, and customized just for you!

Already a member?

Sign In Now »